Dementia may not always be the threat it is now. Here’s why
Obesity and diabetes, more common in recent decades, could lead to more dementia, but much touted new drugs that reduce them ...
At-home smell test could detect Alzheimer’s disease years before symptoms start
Researchers at Mass General Brigham may have developed an easy and inexpensive way to detect early signs of dementia.
‘I wish I had known more’: Barbara Corcoran shares family’s Alzheimer’s journey and resources
For years, entrepreneur Barbara Corcoran has put her skills at the forefront of investing in optimistic businesses through ...
Alzheimer’s-related dementia could be prevented by experimental drug, researchers say
An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.That’s ...
Dementia: a story with many victims: Symptoms and challenges of Alzheimer’s
In the mild Alzheimer’s stage, a person is able to function independently but suffers from common difficulties. These include ...
Breakthrough Drug Cuts Alzheimer’s Risk by 50% in High-Risk Patients
A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...
Rolling Out2d
New study reveals hidden genetic risks for Alzheimer’s
New research identifies 16 genes linked to Alzheimer's risk while experts emphasize powerful lifestyle changes that could ...
Brain-Boosting Workouts? High Cardiorespiratory Fitness Associated With Lower Dementia Risk
People who are genetically predisposed to dementia may lower their risk by as much as 35% by improving their ...
PhillyVoice1d
A subtle loss of smell may be an early sign of Alzheimer's disease
Olfactory tests may be a tool to identify dementia in its initial stages — when interventions are most beneficial, ...
Alzheimer’s & Dementia support now at The Highland Center
Are you caring for a person living from Alzheimer’s or dementia? The Highland Center announces its new ‘Adult Day Center ...
Medscape8h
Alzheimer Drug Donanemab Gets No-Go From European Regulator
The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the treatment of Alzheimer's disease.
Alzheimer's Society1d
Alzheimer’s Society and the BBC work together on dementia season
With support from Alzheimer's Society the BBC has launched special curations on BBC iPlayer and BBC Sounds.